Proposal to list medical devices supplied by Connected Healthcare Systems Limited

Hospital devices Consultation Closed

Te Pātaka Whaioranga - Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.

What we’re proposing

Pharmac is seeking feedback on a proposal to list medical devices supplied by Connected Healthcare Systems Limited (“Connected Healthcare”) in Part III of Section H of the Pharmaceutical Schedule from 1 March 2024 in the following categories:

Consultation closes at 4pm, Monday 05 February 2024 and feedback can be emailed to

What would the effect be?

From 1 March 2024, Connected Healthcare’s range of medical devices in the categories above would be listed under a national agreement for all Te Whatu Ora Hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).

The Agreement would not be for sole supply, with Te Whatu Ora continuing to be able to purchase other suppliers’ brands of Critical Care and Patient Assessment, Monitoring and Treatment devices.

The Agreement would supersede any existing Te Whatu Ora contracts with this supplier for the medical devices listed in Schedule 1 in the Agreement. Any device listed in the Pharmac Agreement and purchased by a Te Whatu Ora Hospital would be at the price, terms and conditions stated in the Agreement, effective from the date of listing on the Pharmaceutical Schedule.

Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.

Who we think will be interested

  • Te Whatu Ora staff including but not limited to the following areas:
    • Clinical engineers and maintenance services
    • ICU/ HDU/ NICU
    • Nurses
    • Patient Monitoring
    • Perioperative staff
    • Procurement and supply chain
    • Radiology
    • Wards and Outpatient Clinics
    • Suppliers and wholesalers

About these products

Critical care

Critical Care is the provision of specialised, continuous, multidisciplinary care for patients in a life-threatening, but treatable, condition. The critical care devices can loosely be grouped into three categories:

  • anaesthetic and invasive ventilation devices
  • neonatal care devices
  • critical care patient monitoring

Patient assessment, monitoring and treatment

Patient assessment, monitoring and treatment devices include equipment and consumable medical devices that are used in a variety of clinical settings to assess, monitor and treat patients. Clinical areas of use include Audiology, Ear, Nose and Throat (ENT), Dermatology, Gastroenterology, Neurosciences and Psychology, Ophthalmology, Somnology, Urology, Vascular Medicine, Wards and Outpatient Clinics.

Why we’re proposing this

Pharmac issued Requests for Proposals (“RFPs”) in 2018 for Multi-category Patient Assessment, Monitoring and Treatment Equipment and Consumables and in 2020 for Anaesthetic Machines, Invasive Ventilators, Neonatal Care and Critical Care Patient Monitoring devices.

Pharmac has been working with suppliers who responded to the RFPs and were successful in being progressed to contract negotiation to seek provisional agreements. This proposal is the latest to arise from these processes.

Details about our proposal

Pharmac has entered into a provisional agreement with Connected Healthcare for the supply of Critical Care and Patient Assessment, Monitoring and Treatment medical devices. The proposal would result in Pharmaceutical Schedule listings for:


Manufacturer Brands

Number of Devices

Critical Care







Patient Assessment, Monitoring and Treatment Devices







Further information, including pricing and contractual details, has been provided to Te Whatu Ora Hospital Procurement personnel. Clinicians interested in further detail on what this change means for their Te Whatu Ora Hospitals should engage with their Procurement teams.

To provide feedback

Send us an email: by 4pm, Monday 05 February 2024.

All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.

Your feedback may be shared

Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.

We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.